Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Radcal IBA  Group

Download Mobile App




Controlled Glucose Oscillations May Restore Insulin Production

By HospiMedica International staff writers
Posted on 08 Nov 2016
A new study suggests that administering controlled pulses of glucose via a microfluidic platform has the potential to reestablish normal insulin production and prevent type 2 diabetes.

Developed by researchers at Florida State University (FSU; Tallahassee, FL; USA), the Dual Oscillator Model (DOM) is a mathematical tool that can simulate experiments with the islets of Langerhans, small clusters of pancreatic cells that contain insulin-producing β-cells. More...
The DOM predicted that an oscillatory stimulus using pulses of glucose to the bloodstream has the potential to reactivate the insulin clock within β-cells that had been halted by exposure to excess glucose.

The researchers tested the hypothesis in a non-diabetic islets of Langerhans mice model. Using a specially engineered microfluidic device, they first delivered a high, steady, glucose stream; as expected, the insulin clock within the mouse islets was deactivated. But when controlled pulses of glucose were reapplied to the islets, the insulin clock was restarted. Moreover, when the flow of glucose followed a feedback loop simulating liver activity, the reactivated islets also recruited other islets to restart their insulin clock. The study was published on October 26, 2016, in PLOS Computational Biology.

“Microfluidics and mathematical modeling can be used together to gain new insights into the mechanisms for hormone secretion,” concluded senior author Richard Bertram, PhD, of the FSU department of mathematics and programs in neuroscience and molecular biophysics. “Our results have potential implications for enhancing insulin pulsatility, and therefore mitigating the development of type 2 diabetes.”

Pancreatic islets manage elevations in blood glucose level by secreting insulin into the bloodstream, governed by islet oscillations such as bursting electrical activity and periodic Ca2+ entry in β-cells. In healthy individuals, β-cells release regular pulses of insulin to restrict the amount of glucose released by the liver, as well as impel body tissues to absorb the glucose. However, in hyperglycemia, a hallmark of type 2 diabetes, the excess glucose suppresses the "inner clock" of β-cells that controls the rhythm of insulin pulses, reducing insulin production.

Related Links:
Florida State University



Platinum Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Infant Resuscitator
Easypuff
Blood Bank Refrigerator
MBR-705GR-PE
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: Professor Bumsoo Han and postdoctoral researcher Sae Rome Choi of Illinois co-authored a study on using DNA origami to enhance imaging of dense pancreatic tissue (Photo courtesy of Fred Zwicky/University of Illinois Urbana-Champaign)

DNA Origami Improves Imaging of Dense Pancreatic Tissue for Cancer Detection and Treatment

One of the challenges of fighting pancreatic cancer is finding ways to penetrate the organ’s dense tissue to define the margins between malignant and normal tissue. Now, a new study uses DNA origami structures... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.